Modeling and Simulation to accelerate development and improve safety of drugs and medical devices and significantly cut R&D costs and time
InSilicoTrials is an emerging startup founded in 2018 by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize Healthcare through an innovative digital simulation platform, where complex computational simulations run in an easy and cost-effective way to hyper- accelerate drug & medical device development. We offer Pharma and MedTech companies state-of-the-art simulation tools that can highly reduce the cost and time of drugs & medical products’ development. The in silico technology can increase the quality of life of millions of patients by allowing cheaper treatments, bringing innovative drugs to the market in a shorter time, together with personalized cures and new solutions for rare diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 30, 2020 | Seed | $3.50M | 1 | United Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
United Ventures | Yes | Seed |